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 Background: It has been reported that bifocal pacing (BiFP) in the 
right ventricle (RV) may be an alternative to unsuccessful left ventricular 
(LV) lead implantation.  
Aim: This study seeks to assess the improvement in the clinical and 
hemodynamic parameters after long term BiFP in patients eligible for cardiac 
resynchronization therapy (CRT), in whom conventional biventricular (BiV) 
implantation was not feasible or failed.  
Methods: The three leads (right atrial appendage, RV apex and RV outflow 
tract) of a BiFP were implanted in 46 patients, among whom16 lost follow 
up within one month of BiFP implantation, so 30 patients (19 male/11 
female) were enrolled in the study with the mean follow up period of 8.7 (± 
6.7) months. All patients had heart failure refractory to medical therapy, New 
York Heart Association (NYHA) functional class of  II, III and IV, ejection 
fraction (EF) ≤ 35 %, left bundle branch block (LBBB) with QRS duration ≥ 
130 milliseconds and functional mitral regurgitation. The parameters (QRS 
duration, NYHA class, EF, and cardiomegaly) were evaluated before and 1, 
3, 6, 12 and 24 months after BiFP implantation. A six minute walk test 
(6MWT) was performed on 7 patients, before and after implantation. 
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Results: The results showed significant improvement in whole parameters, 
after both acute and long term BiFP. The improvement increased during 
subsequent follow up. 
Conclusions: The study concluded that BiFP is a feasible type of CRT in 
patients with refractory HF and can be used as an alternative to biventricular 
pacing when LV lead implantation is infeasible. 
 
Keywords: Bifocal right ventricular pacing, cardiac resynchronization 
therapy, heart failure 
 
Introduction 
Heart failure (HF) is an increasingly common condition in the 
developed world, which causes significant morbidity and mortality (Cleland 
et al., 2001). The treatment of congestive HF has improved with the great 
therapeutic advances of the past two decades, with clear reductions in the 
morbidity and mortality of these patients. However, many patients remain 
with significant symptoms and incur a high number of hospital admissions 
(Rocha et al., 2007)/ This is why an electromechanical approach (through 
pacing) is acceptable in certain patients as a useful adjunct to optimal 
medical therapy (Cazeau et al., 2001; Abraham et al., 2002).  
Dyssynchrony; atrioventricular (AV) delay, inter- and intra-
ventricular delay (VD); which are common in patients with HF  (Paisey & 
Morgan, 2004), are a consequence of progressive global or focal degradation 
of the myocardium, caused by the heterogenous propagation of cardiac 
electrical activity (Cazeau et al., 1998).  First-degree heart block is common 
in, and contributes to HF (Panidis et al., 1986), and is a reliable indicator of 
AV conduction delay. Inter- VD defined as the time interval between RV 
and LV depolarization (mostly LV delay as the common conduction defect 
in ischaemic and cardiomyopathic ventricles) resembles LBBB both 
electrically and mechanically (Haber & Leatham, 1965).  Prolonged AV 
intervals result in the loss of cardiac output (C.O) due to reduced ventricular 
filling time and pressure and increased mitral regurgitation (MR) (Panidis et 
al., 1986).  
CRT with biventricular (BiV) pacing is recommended in patients 
with advanced HF, severe systolic dysfunction (LVEF ≤ 35%) and intra-
ventricular conduction delay -intra-VCD- (QRS ≥ 120ms). 
Resynchronization may improve pump performance and reverse the 
deleterious process of ventricular remodeling (Saxon et al., 2010). CRT with 
BiV (in which the left lead implantation is achieved by transvenous insertion 
into tributaries of the coronary sinus) (Paisey & Morgan, 2004) can restore 
cardiac synchrony in some patients and is associated with improved systolic 
function and clinical outcomes (Abraham et al., 2002). Although a 
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substantial hemodynamic effect is evident from many studies, the technique 
used for LV lead implantation is associated with many limitations, including 
a definite learning curve, failure to implant, a relatively high dislocation rate, 
and additional complications such as phrenic nerve stimulation (Vlay 2004, 
2006). 
 BiFP, using two pacing sites in the RV: RV apex (RVA) and RV 
outflow tract (RVOT), has been developed as an alternative way to achieve 
cardiac resynchronization in special situations (Barold et al., 2008b). In 
contrast to that of CRT, the technique used for placing an RVOT lead is 
associated with a short learning curve, no special delivery tools are involved 
and the technical success rate is very high. Several non-randomized long-
term studies of CRT candidates, including single case reports, suggest that 
bifocal RV pacing may yield a sustained hemodynamic benefit with 
improvement in LV function (da Silva, 2004; O’Donnell et al., 2005).  In two 
studies (Saxon et al., 2003; Res et al., 2007), clinical and echocardiographic 
parameters have demonstrated significant improvement in a NYHA class, 
6MWT, EF, and grade of MR at three months compared to baseline. 
The aim of the present study is to assess the long-term benefit and 
effectiveness of bifocal right ventricular pacing implantation (as an 
alternative to the standard method) through assessing the clinical and 
echocardiographic parameters of heart failure patients who do not respond to 
optimal pharmacological therapy.  
Methods 
This study is a simple descriptive design. It includes the consecutive 
patients who were referred to the Sulaimanyah Center for Heart Disease 
(SCHD) and Nasriah Heart Center (NHC) for CRT implantation, from 2005 
to 2011. Bifocal pacing was chosen for the following reasons: failed 
implantation using the conventional technique, whole facilities of 
conventional CRT implantation (coronary sinus entrance) being unavailable, 
and, lastly physician's choice. The inclusion criteria were as follows: a) Heart 
failure patients with NYHA class II, III and IV despite optimal medical 
therapy; b) LVEF ≤ 35%; c) LBBB with QRSd ≥ 130; and d) Functional 
MR. 46 patients fulfilled the inclusion criteria, 16 of them lost follow up for 
more than one month, so the number of patients included in the study was 
30.  
Patients were kept on the following medications: ACE-inhibitors, 
Beta-blockers, loop diuretics and spironolactone, for at least six weeks prior 
to implantation; all patients were in sinus rhythm. The study was approved 
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Implantation procedure 
The implantation was done under local anesthesia, the subclavian 
vein was accessed through three separate punctures and a pulse generator 
pocket was formed. 
Two or three guide wires were introduced and a pealaway introducer 
sheath, size 7, 8 or 9 French was used to introduce the leads. Leads from St 
Jude Medical (Tendril TM ST, AV PLUS TM DX), Medtronic (CAPSUREFIX 
R), and Biotronic (Selox SR, JT) were used. The leads were introduced under 
fluoroscopic guidance. The first lead was positioned at the right ventricular 
apex, R wave sensing was done and the pacing threshold was measured. The 
accepted threshold was around 0.5-1.5 volts. The second lead (the active 
fixation lead) was positioned at the RVOT by making a wide curve in the 
stylus in the pacing lead to attain a position at the RVOT. The third lead, a J 
shaped passive or active fixation lead, was positioned either in the RAA or in 
the lateral atrial wall. A P wave sensing measurement was made, and a 
sensing threshold > 2 mA was accepted.  
Eight patients (26.7 %) who were eligible for CRT also met the 
criteria for ICD implantation (had resuscitated VT /VF or suspected VT 
induced syncope), so CRT-D (CRT with defibrillator) implanted in them, 
while the other 22 (73.3 %) were implanted with CRT alone (CRT-P). Then 
ICD testing of defibrillation thresholds including arrhythmia induction was 
conducted. R-wave of more than 6 mA were accepted. 
The pacemaker boxes of ST JUDE Medical (Frontier I, Frontier II 
5596, Epic HF, Atlas HF) in 26 patients, Medtronic (InSync Sentry 8040, 
7272) in 3 patients, and BIOTRONIC (Talos DR) with the Y-connector for 
the two RV leads in 1 patient were implanted subcutaneously in the left 
prepectoral region. The RVA lead was connected to the pacemaker's RV 
port, the RVOT lead to the LV port and the RA lead was connected to the 
atrial port. Then the leads and device were secured, and the pulse generator 
pocket closed. Appropriate post-operative antibiotics were given to the 
patients. The estimated procedural time was 2 hours. No in-hospital death 
occurred during the procedure. Three patients developed complete heart 
block (CHB) during the procedure, but were recovered after RV pacing, two 
developed arrest and one ventricular tachycardia (VT), but they were 
resuscitated and returned to sinus rhythm. 
Optimization of the device was carried out 10 days post implantation, 
when most (26) of the pacemaker boxes used for bifocal CRT were SJM 
Frontier I and Frontier II with the facility of Quick Optimization software for 
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Patient follow-up approaches: 
The patients were clinically followed up by using the following 
approaches:  
1) A 12-lead surface ECG for measuring QRSd in milliseconds (ms).  
2) Echocardiography: by using a 2-dimensional (2-D) Doppler, M-mode, to 
assess the LVEF.  
3) Assessment of  NYHA functional class.  
4) 6MWT was done in 7 patients;  according to the American Thoracic 
Society (ATS) guidelines (2002) [20].  
5) CXR was undertaken for the degree of cardiomegaly. Cardiomegaly is 
divided into mild, moderate and severe, according to the cardiothoracic ratio 
(CTR). CTR above 50% is regarded as cardiomegaly, CTR of ( 51%-55 % ) 
as mild, ( 56%-60 % ) as moderate and > 60% as severe cardiomegaly. 
All the above clinical data were obtained at baseline and were 
repeated after implantation (during 1, 3, 6, 12 and 24 months follow up in all 
the patients who completed their follow up), except the 6MWT which was 
performed in 7 patients and was done at base line and 1 and 3 months of 
follow up. The mean follow up periods were 8.7 (1-24) months. Pacemaker 
programming was performed at 10 days, at the first and second month follow 
ups and bimonthly thereafter. During each visit the patients were examined 
for any other complications.  
Statistical analysis:  
Statistical analysis was performed using SPSS version 13. 
Descriptive statistics were calculated for all variables; statistical analysis was 
done to find the relations between variables by using Chi-square, t-test, and 
analysis of variance (ANOVA). All numerical variables were recorded as 
mean ± standard deviation. A P-value < 0.05 was considered significant.  
Results 
        Thirty patients were included in the study, their ages ranging between ( 
23 and  74 ) years with the mean age of 55.63 ± 10.14 years, 19 of the 
patients (69.3 %) were male. The mean NYHA class was ( 3.2 ± 0.6); the 
mean LVEF was ( 33.2 ± 6.0 ) %; the mean QRSd was ( 160 ± 16.8 ) ms; 
and the mean 6MWD was ( 195.8 ± 91.2 ) m. All the patients had chronic 
HF refractory to medical therapy. The causes of HF were: coronary artery 
disease (ischemic CMP) in 6 (18.4 %) of the patients and idiopathic (non-
ischemic) DCMP in 24 (81.6 %) of the patients.  
Remarkable improvements in clinical status, NYHS class, LVEF and 
a shortening in QRS duration were noticed acutely after BiFP. The 
improvement was maintained and increased progressively during long-term 
follow up as shown in the figures below (Figures 1, 2, 3, 4, 5, 6 & 7). These 
improvement were statistically significant, except for the 6MWT (P-value = 
0.123). 
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Only three patients (10%) showed no changing or worsening after 
BiFP in most parameters and they were regarded as non-responders. There 
were two patients with no changes at the begining in any of the parameters 
except for QRS narrowing, but later on (after 6 months in one of them and 9 
months in the other) they began to improve; these patients are regarded as 
late-responders. 
Complications during follow up 
Complications include: Hematoma (1 case), infection (1 case), 
pulmonary edema (1 case), non-sustained ventricular tachycardia (VT) (2 
cases), supraventricular tachycardia (SVT) (1 case) and AF (5 cases). No 
lead dislodgement or fracture occurred during the study period.  
 
Figure 1. Mean QRS duration, before and after BiFP during different follow up periods (at 















Figure 2. Mean LVEF (%) at baseline and after 1, 3, 6, 12 and 24 months of follow up. 






























































Figure 5. Mean cardiothoracic ratio at baseline and after 1 and 3 months of BiFP. 
 
Figure 6. CXR of a patient, showing decrease in cardiac size after 6 months of BiFP 
 
 
Figure 7. LVEF before (35%) and after 1 (49%) and 2 months (53%) of BiFP 






Figure 8. ECG before (A) and directly after (B) BiFP. 
 
Discussion 
CRT through LV implantation via C.S cannulation is a widely used 
method; it causes a great improvement in the hemodynamic and functional 
status of patients with refractory HF. However, this technique is sometimes 
unsuccessful because of failure to cannulate C.S or enter its branch veins due 
to anatomical factors or severe scarring. Stimulation through cardiac veins, 
in addition to the difficulty of access, causes additional problems such as: the 
need for a special lead, long-term stability of the lead, inability to obtain an 
adequate pacing threshold, cardiac vein phlebitis, and problems with 
removing chronicle leads (Pachón et al., 2001, Chudzik et al., 2009). The 
only endocardial solution for those patients in whom CRT is not feasible is 
an attempt to pace an additional site in the RV (choosing RVOT instead of 
LV) (Vlay, 2003). 
Restoring the origin of depolarization to the high ventricular septum, 
with BiFP through RVOT pacing, restores a more favorable contraction 
pattern. In addition, RVOT pacing is usually associated with good sensing 
and low thresholds due to viable myocardium in the proximal septum in 
which the blood supply is usually preserved. Low pacing thresholds also 
improve battery longevity in contrast to LV pacing when myocardium is 
sometimes so scarred that it cannot sense or pace (Vlay, 2004). LV pacing 
also needs prolonged time in the laboratory, which has medical and financial 
A 
B 
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consequences. Long fluoroscopy time results in radiation exposure to the 
patient and physician. Implanting aan RVOT electrode, in contrast, takes 
only a few minutes (Vlay, 2004). 
The present study shows clearly the significant improvement in both 
the hemodynamic and functional status of patients treated with BiFP with an 
indication for CRT, who are not feasible for CRT implantation (either due to 
failure of the procedure or inaccessibility of the tools for C.S cannulation).  
Acute effect of BiFP 
There are several studies and case reports on the acute effect of BiFP: 
Early in 1997, Buckingham et al. tested different RV pacing sites, but the 
authors failed to show any significant change in the LVEF, C.O and peak LV 
dp/dt during intrinsic rhythm, atrial pacing and DVI pacing at the RVA, the 
RVOT, and both RV sites. However, the highest absolute values of dp/dt 
were observed during sinus rhythm and the lowest with RVA pacing. This 
parameter tended to improve progressively with pacing in the RVOT and at 
both sites (i.e. bifocal pacing).  
          Pachón et al. (2001)  showed the advantages of BiFP over both RVA 
and RVOT pacing in a heterogeneous group of 39 DCMP patients. They 
report a significant (12%) increase in LVEF during BiF stimulation 
compared with RVA stimulation, and a decrease in QRS duration by 51.5 
ms, together with a 50.1% reduction in QoL score. The total follow up period 
was only 30 days. In the present study, the acute improvement in 
hemodynamic status was about the same as the study by Pachón et al. 
(2001).  
In a case report by Vlay (2003), BiF was implanted in two patients 
after failure to secure C.S cannulation. He also showed that BiFP decreased 
QRS duration in one of the cases by 40 ms after 2 months of follow up. 
NYHA improved, but he did not report any improvement in hemodynamics. 
There are studies which used Tissue Doppler Imaging (TDI) to assess 
the level of dyssynchrony in patients with BiFP ( Matsushita et al. 2005, 
Martiniello et al. 2005, Lane et al. 2007). The results showed that BiFP was 
effective in reducing LV dyssynchrony. It was concluded that BiF improves 
LV hemodynamic by decreasing inter- and intra-VCDs. Unfortunately, inter 
and intra ventricular mechanical delay was not assessed in the preset study, 
though it is important in the course of following up patients and in choosing 
patients for CRT implantation.      
Chudzik et al. (2009), in their study, which is the most recently 
published study of BiFP, assess BiFP in 8 patients with severe HF. It is 
shown that BiFP provided an improvement in HF class in all patients after 3 
months of follow up. Echocardiography revealed a significant increase in CO 
and LVEF but the only discrepancy in the results from the present study is 
that, among the 8 patients, only 3 showed a reduction in QRSd, where as in 
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the remaining patients QRS otherwise widened. This may be due to the small 
size of the study group. 
Long term effect of BiFP 
A number of studies and reports have been written on the long term 
effect of BiFP: Vlay (2004)  evaluates NYHA class in 22 patients after 
unsuccessful CRT implantation followed by using a BiFP type. During a 
seven-month follow-up period, the NYHA class improved. Most of them 
became NYHA I and II after 7 months of follow up. Significant 
improvement was achieved in the NYHA functional class in the present 
study also, for 60% of the patients became NYHA I by the sixth month of 
follow up. Malinowski& Jacob (2003), in their study assessing clinical 
outcomes in CRT, find that 6 of the 49 patients had BiF implants. BiF 
patients improved in NYHA class and LVEF, and so did BiV patients after 
20 months. QRS duration remained unchanged; results were statistically 
insignificant, due to the small number of BiF patients. 
The first published long-term (12 months), non-randomized study of 
BiF was performed by O'Donnell et al. (2005). He reports 6 patients in 
whom BiF increased LVEF, and resulted in the reduction in MR and in the 
NYHA functional class. The mean NYHA showed improvement from 3.1 to 
1.4. Additionally, these results were similar to changes observed in 44 
patients with conventional BiV. The present study is consistent with the 
study of O’Donnell. It was observed that the mean NHYA Class improved 
from 3.2 to 1.6 by the twelfth month of follow up. A decrease in QRSd and 
NYHA class with an increase in LVEF is also found in a study published by 
Riedlbuchora (2005), who investigated 19 patients with a mean follow up 
period of 12 months. 
Zamparelli (2005), studied 25 patients with a mean follow up period 
of 18 months. He reports a QRS narrowing from 157 to 115 ms, increase in 
EF from 32% to 41%, lower degree of MR and improvement in NYHA class 
from 3.5 to 2.0. These results are about the same as in the study published by 
Diotallevi (2006), who implanted BiFP in 27 patients but placed the lead in 
the parahisian region instead of the RVOT site. The patients were followed 
up for 20 months, QRS showed a significant narrowing from 190 to 152 ms, 
EF increased (1-29%), NYHA class showed significant improvement (3.4-
1.9). The results from these two studies are very near to those of the present 
study during a long term follow up of more than 12 months. 
In the BRIGHT study which was the first randomized, long term 
cross over study [16], the patients were followed up for 6 months. BiFP 
significantly improved LVEF, decreased the NYHA class from 2.8 to 2.3 and 
decreased the QoL score. There was also a small but significant decrease in 
QRS width from 180 to171 ms.  
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Wojciuk et al. (2007), in their case report, mention an improvement 
in LVEF from 23% to 43.4% after 4 months of BiFP and after switching off 
the BiF device, EF was 32.6%. The findings were supportive of a sustained 
effect of RVOT pacing on EF and beneficial results on cardiac remodeling.  
In the present study, 3 patients (10%) did not respond to the BiFP. In 
one of the cases there was an improvement in most of the parameters in the 
first month following BiF but later the EF and NYHA class of this patient 
declined to that of the baseline. The other 2 patients following BiF, had their 
EF and NYHA class decreased or remaining about the same, so they were 
regarded as non-responders. The explanation of these non-responders is 
mostly due to the AV optimization problem, or may be due to the absence of 
re-ssynchrony despite QRS narrowing, or to such extensive scarring in 
myocardium due to IHD that the pacing was ineffective, or that the exact 
RVOT site had not been secured, for the same reason.  
There was significant improvement acutely following implantation 
(mostly after one month) in 25 patients, in particular a large reduction in 
QRSd was noticed directly or within a month of BiFP (48.8 ms) while at the 
twenty-fourth month follow up there was only minor change (11.1 ms) 
compared to the 1st month. This QRS narrowing reflects the concomitant 
activation of the left lateral wall and the septum, abating any delay between 
them, and reflecting that on the QRS width. With chronic pacing, there was 
progressive improvement of parameters and more improvement in the 
patient's functional class. Parameters which show great improvement after 
long term BiF are the cardiothoracic ratio and LVEF, both of which  may be 
due to LV remodeling following BiFP.  
Another parameter tested in this study, is 6MWD. There was a 
marked increase in the mean walking distance from 196 m to 286m, after 
1month and to 324 m, after 3 months of BiFP; however the increase was not 
statistically significant. Only in a few studies was 6MWD tested, but they all 
show an increase in the mean walking distance after BiFP (Res et al. 2007, 
O' Donnel et al, 2005, Chudzik et al., 2009, Diotallevi et al., 2006). 
This study is the first study on BiFP conducted in Iraq and there has 
been only one study on CRT performed in Iraq (Basheer and Al-Hamdi, 
2004). The writers implanted a BiV device in 21 patients, and a BiF in 1 
patient (because of BiV failure). Significant improvement was seen in 
clinical and echocardiographic parameters after the 1 month follow up. They 
state that the results for this patient were similar to those with BiV CRT 
implantation. 
Limitations of the study 
This study included also a retrospective patient group in whom a BiF 
was implanted before the start of the study because the number of patients 
European Scientific Journal   August 2013  edition vol.9, No.24  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
274 
having a BiF device implanted was not quite sufficient and the time of the 
study was limited, to allow for this long follow up period. 
Not all  the patients included in the study completed the 24 months of 
follow up, so it would have been better to take a larger sample size. 
Only in 7 patients was 6MWT tested. This is because they were either 
in a retrospective group or they had a contraindication about doing this test; 
sometimes the patients were unable or unwilling to be tested. 
Conclusion 
Bifocal right ventricular pacing is a feasible type of cardiac 
resynchronization therapy. It can improve a patient's functional status and 
hemodynamic parameters significantly and can be used as a treatment in 
CHF patients who are indicated for BiV CRT in the following situations: 
when the attempts of LV lead implantation are unsuccessful, when they are 
at high risk of prolonged procedural time or thoracotomy for epicardial lead 
implantation and when the LV lead implantation, and C.S cannulation tools 
are unavailable. 
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